DJIA 17,956.39 -78.54 -0.44%
NASDAQ 5,019.20 24.60 0.49%
S&P 500 2,098.53 -1.87 -0.09%
market minute promo

66.73 0.87 (1.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $66.74 1.33%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.11
Previous Close $65.86
Daily Range $66.09 - $67.53
52-Week Range $46.30 - $69.20
Market Cap $110.9B
P/E Ratio 54.88
Dividend (Yield) $1.48 (2.2%)
Ex-Dividend Date
Dividend Pay Date
04/01/15
05/01/15
Volume 5,242,226
Average Daily Volume 6,362,045
Current FY EPS $1.69

Sector

Healthcare

Industry

Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary Rss Feed

Is Bristol-Myers Squibb. Co. About to Fall Apart?

Bristol-Myers Squibb is pinning its future on a new class of drugs that could be game-changers in the fight against cancer. The Street, though, may be wildly overestimating their commercial potential. Here's why.

Benzinga's Top Upgrades

Bristol-Myers Squibb Company (BMY) Highlighted As Momo Momentum Stock

Top Analyst Upgrades and Downgrades: GE, IBM, Bristol-Myers, Encana, Halliburton, Rio Tinto, WhiteWa

Top Analyst Upgrades and Downgrades: GE, IBM, Bristol-Myers, Encana, Halliburton, Rio Tinto, WhiteWave and More

Morgan Stanley Says 'Buy The Leader In IO,' Upgrades Bristol-Myers To Overweight

Merck's Keytruda Tops Melanoma, Lung Cancer Studies - Analyst Blog

Bristol-Myers' Study on Opdivo Halted on Early Success - Analyst Blog

3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings

Bristol-Myers Squibb Reports First Randomized Study Evaluating Opdivo+Yervoy Regimen Shows Superior

Bristol-Myers Squibb Reports First Randomized Study Evaluating Opdivo+Yervoy Regimen Shows Superior Efficacy Related to Yervoy Alone

Bristol-Myers immunotherapy combo promising in melanoma-study

See More BMY News...

BMY's Top Competitors

BMY $66.73 (1.32%)
Current stock: BMY
JNJ $100.35 (0.14%)
Current stock: JNJ
NVS $104.22 (1.94%)
Current stock: NVS
RHHBY $35.87 (0.69%)
Current stock: RHHBY